Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
International Journal of Clinical Practice. Supplement
|
December 6, 2007
Partnering with governments and other institutions: driving change in diabetes care
K G M M Alberti, C J Bailey, L Blonde, et al.
Diabetes, Obesity & Metabolism
|
July 2, 2010
Patient-reported outcomes following treatment with the human GLP-1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with type 2 diabetes
B W Bode, M A Testa, M Magwire, et al.
Diabetes, Obesity & Metabolism
|
July 21, 2009
Comparison of vildagliptin and thiazolidinedione as add-on therapy in patients inadequately controlled with metformin: results of the GALIANT trial--a primary care, type 2 diabetes study
L Blonde, S Dagogo-Jack, M A Banerji, et al.
The American Journal of Clinical Nutrition
|
June 6, 2000
Long-term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia
J W Anderson, M H Davidson, L Blonde, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
December 8, 2019
Hypoglycaemia is reduced with use of inhaled Technosphere<sup>®</sup> Insulin relative to insulin aspart in type 1 diabetes mellitus
E R Seaquist, L Blonde, J B McGill, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
April 26, 2008
The effect of the availability of inhaled insulin on glycaemic control in patients with Type 2 diabetes failing on oral therapy: the evaluation of Exubera as a therapeutic option on insulin initiation and improvement in glycaemic control in clinical practice (EXPERIENCE) trial
S Del Prato, L Blonde, L Martinez, et al.
Diabetes, Obesity & Metabolism
|
June 17, 2006
Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes
L Blonde, E J Klein, J Han, et al.
Diabetes, Obesity & Metabolism
|
May 13, 2015
Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy
S E Inzucchi, K Tunceli, Y Qiu, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
International Journal of Clinical Practice. Supplement
|
December 6, 2007
Partnering with governments and other institutions: driving change in diabetes care
K G M M Alberti, C J Bailey, L Blonde, et al.
Diabetes, Obesity & Metabolism
|
July 2, 2010
Patient-reported outcomes following treatment with the human GLP-1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with type 2 diabetes
B W Bode, M A Testa, M Magwire, et al.
Diabetes, Obesity & Metabolism
|
July 21, 2009
Comparison of vildagliptin and thiazolidinedione as add-on therapy in patients inadequately controlled with metformin: results of the GALIANT trial--a primary care, type 2 diabetes study
L Blonde, S Dagogo-Jack, M A Banerji, et al.
The American Journal of Clinical Nutrition
|
June 6, 2000
Long-term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia
J W Anderson, M H Davidson, L Blonde, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
December 8, 2019
Hypoglycaemia is reduced with use of inhaled Technosphere<sup>®</sup> Insulin relative to insulin aspart in type 1 diabetes mellitus
E R Seaquist, L Blonde, J B McGill, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
April 26, 2008
The effect of the availability of inhaled insulin on glycaemic control in patients with Type 2 diabetes failing on oral therapy: the evaluation of Exubera as a therapeutic option on insulin initiation and improvement in glycaemic control in clinical practice (EXPERIENCE) trial
S Del Prato, L Blonde, L Martinez, et al.
Diabetes, Obesity & Metabolism
|
June 17, 2006
Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes
L Blonde, E J Klein, J Han, et al.
Diabetes, Obesity & Metabolism
|
May 13, 2015
Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy
S E Inzucchi, K Tunceli, Y Qiu, et al.
Page
of 4